Dietary suppression of the mammary CD29hiCD24+ epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice

Stem Cell Research

Volumn 11, Issue 3, 2013, Pages 1149-1162

  Rahal, Omar M ^a   Machado, Heather L ^d   Montales, Maria Theresa E ^a,b   Pabona, John Mark P ^b   Heard, Melissa E ^b   Nagarajan, Shanmugam ^a,b   Simmen, Rosalia C M ^a,b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BETA1 INTEGRIN; CD24 ANTIGEN; ESTRADIOL; INTERLEUKIN 6; NOTCH2 RECEPTOR; PROGESTERONE; STAT1 PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CANCER INCIDENCE; CANCER RISK; CELL CULTURE; CELL PROLIFERATION; CELL SUBPOPULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; LATENT PERIOD; MALE; MAMMARY GLAND; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; WEANING;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD29; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DIET; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; RECEPTORS, VIRUS; RISK FACTORS; TRANSCRIPTOME; WNT1 PROTEIN;

EID: 84883650392     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.08.006     Document Type: Article

References (53)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
2. Asselin-Labat M.L., Shackleton M., Stingl J., Vaillant F., Forrest N.C., Eaves C.J., Visvader J.E., Lindeman G.J. Steroid hormone receptor status of mouse mammary stem cells. J. Natl. Cancer Inst. 2006, 98:1011-1014.
3. Asselin-Labat M.L., Vaillant F., Sheridan J.M., Pal B., Wu D., Simpson E.R., Yasuda H., Smyth G.K., Martin T.J., Lindeman G.J., Visvader J.E. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802.
4. Balko J.M., Miller T.W., Morrison M.M., Hutchinson K., Young C., Rinehart C., Sánchez V., Jee D., Polyak K., Prat A., Perou C.M., Arteaga C.L., Cook R.S. The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:221-226.
5. Brit K., Ashworth A., Smalley M. Pregnancy and the risk of breast cancer. Endocr. Relat. Cancer 2007, 14:907-933.
6. Cabodi S., Taverna D. Interfering with inflammation: a new strategy to block breast cancer self-renewal and progression?. Breast Cancer Res. 2010, 12:305-306.
7. Cardiff R.D., Anver M.R., Gusterson B.A., Hennighausen L., Jensen R.A., Merino M.J., Rehm S., Russo J., Tavassoli F.A., Wakefield L.M., Ward J.M., Green J.E. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000, 19:968-988.
8. Chaffer C.L., Brueckmann I., Scheel C., Kaestli A.J., Wiggins P.A., Rodrigues L.O., Brooks M., Reinhardt F., Su Y., Polyak K., Arendt L.M., Kuperwasser C., Bierie B., Weinberg R.A. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:7950-7955.
9. Cho R.W., Wang X., Diehn M., Shedden K., Chen G.Y., Sherlock G., Gurney A., Lewicki J., Clarke M.F. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 2008, 26:364-371.
10. Clarke M.F. What can we learn about breast cancer from stem cells?. Adv. Exp. Med. Biol. 2008, 458:780-783.
11. Dave B., Eason R.R., Till S.R., Geng Y., Velarde M.C., Badger T.M., Simmen R.C. The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 2005, 26:1793-1803.
12. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003, 17:1253-1270.
13. Farnie G., Clarke R.B. Mammary stem cells and breast cancer - role of Notch signaling. Stem Cell Rev. 2007, 3:169-175.
14. Fink B.N., Steck S.E., Wolff M.S., Britton J.A., Kabat G.C., Gaudet M.M., Abrahamson P.E., Bell P., Schroeder J.C., Teitelbaum S.L., Neugut A.I., Gammon M.D. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol. Biomark. Prev. 2007, 16:2285-2292.
15. Fu Y.P., Edvarsen H., Kaushiva A., Arhancet J.P., Howe T.M., Kohaar I., Porter-Gill P., Shah A., Landmark-Høyvik H., Fosså S.D., Ambs S., Naume B., Børrensen-Dale A.L., Kristensen V.N., Prokunina-Ollson L. Notch2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without Tp53 mutations. Mol. Cancer 2010, 9:113.
16. Ginestier C., Liu S., Diebel M.E., Korkaya H., Luo M., Brown M., Wicinski J., Cabaud O., Charafe-Jauffret E., Birnbaum D., Guan J.L., Dontu G., Wicha M.S. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest. 2010, 120:485-497.
17. Iliopoulos D., Hirsch H.A., Wang G., Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1397-1402.
18. Joshi P.A., Jackson H.W., Beristain A.G., Di Grappa M.A., Mote P.A., Clarke C.L., Stingl J., Waterhouse P.D., Khokha R. Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807.
19. Kakarala M., Brenner D.E., Korkaya H., Cheng C., Tazi K., Ginestier C., Liu S., Dontu G., Wicha M.S. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res. Treat. 2010, 122:777-785.
20. Korde L.A., Wu A.H., Fears T., Nomura A.M., West D.M., Kolonel L.N., Pike M.C., Hoover R.N., Ziegler R.G. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol. Biomark. Prev. 2009, 18:1050-1059.
21. Korkaya H., Paulson A., Charafe-Jauffret E., Ginestier C., Brown M., Dutcher J., Clouthier S.G., Wicha M.S. Regulation of mammary stem/progenitor cells by PTEN/Akt/β-catenin signaling. PLoS Biol. 2009, 7:1-14.
22. Korkaya H., Liu S., Wicha M.S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 2011, 121:3804-3809.
23. LaMarca H.L., Visbal A.P., Creighton C.J., Liu H., Zhang Y., Behbod F., Rosen J.M. CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland. Stem Cells 2010, 28:535-544.
24. Li Y., Welm B., Podsypanina K., Huang S., Chamorro M., Zhang X., Rowlands T., Egeblad M., Cowin P., Werb Z., Tan L.K., Rosen J.M., Varmus H.E. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15853-15858.
25. Lim E., Vaillant F., Wu D., Forrest N.C., Pal B., Hart A.H., Asselin-Labat M.L., Gyorki D.E., Ward T., Partanen A., Feleppa F., Huschtscha L.I., Thorne H.J., Fox S.B., Yan M., French J.D., Brown M.A., Smyth G.K., Visvader J.E., Lindeman G.J. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat. Med. 2009, 15:907-913.
26. Litton J.K., Arun B.K., Brown P.H., Hortobagyi G.N. Aromatase inhibitors and breast cancer prevention. Expert Oncol. Pharmacother. 2012, 13:325-331.
27. Liu B.Y., McDermott S.P., Khwaja S.S., Alexander C.M. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4158-4163.
28. Liu S., Dontu G., Mantle I.D., Patel S., Ahn N.S., Jackson K.W., Suri P., Wicha M.S. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant mammary stem cells. Cancer Res. 2006, 66:6063-6071.
29. Liu S., Ginestier C., Ou S.J., Clouthier S.G., Patel S.H., Monville F., Korkaya H., Heath A., Dutcher J., Kleer C.G., Jung Y., Dontu G., Taichman R., Wicha M.S. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 2011, 71:614-624.
30. Lydon J.P., Ge G., Kittrell F.S., Medina D., O'Malley B.W. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 1999, 59:4276-4284.
31. Montales M.T., Rahal O.M., Kang J., Rogers T.J., Prior R.L., Wu X., Simmen R.C. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells. Carcinogenesis 2012, 33:652-660.
32. Oskarsson T., Acharyya S., Zhang X.H., Vanharanta S., Tavazoie S.F., Morris P.G., Downey R.J., Manova-Todorova K., Brogi E., Massagué J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 2011, 17:867-874.
33. Pabona J.M., Simmen F.A., Nikiforov M.A., Zhuang D., Shankar K., Velarde M.C., Zelenko Z., Giudice L.C., Simmen R.C. Kruppel-like factor 9 and progesterone receptor coregulation of decidualizing endometrial stromal cells: implications for the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab. 2012, 97:E376-E392.
34. Park S.Y., Gönen M., Kim H.J., Michor F., Polyak K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J. Clin. Invest. 2010, 120:636-644.
35. Rahal O.M., Simmen R.C. PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis 2010, 31:1491-1500.
36. Rahal O.M., Pabona J.M.P., Kelly T., Huang Y., Hennings L.J., Prior R.L., Al-Dwairi A., Simmen F.A., Simmen R.C.M. Suppression of Wnt1-induced mammary tumor growth and lower serum insulin in offspring exposed to maternal blueberry diet suggest early dietary influence on developmental programming. Carcinogenesis 2013, 34:464-474.
37. Scheffer G.L., de Jong M.C., Monks A., Flens M.J., Hose C.D., Izquierdo M.A., Shoemaker R.H., Scheper R.J. Increased expression of beta 2-microglobulin in multidrug-resistant tumour cells. Br. J. Cancer 2002, 86:1943-1950.
38. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
39. Simmen R.C., Eason R.R., Till S.R., Chatman L., Velarde M.C., Geng Y., Korourian S., Badger T.M. Inhibition of NMU-induced mammary tumorigenesis by dietary soy. Cancer Lett. 2005, 224:45-52.
40. Sørlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Thorsen T., Quist H., Matese J.C., Brown P.O., Botstein D., Lønning P.E., Børresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10869-10874.
41. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
42. Su Y., Simmen R.C.M. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates β-catenin signaling in mammary epithelial cells. Carcinogenesis 2009, 30:331-339.
43. Su Y., Eason R.R., Geng Y., Till S.R., Badger T.M., Simmen R.C. In utero exposure to maternal diets containing soy protein isolate, but not genistein alone, protects young adult rat offspring from NMU-induced mammary tumorigenesis. Carcinogenesis 2007, 28:1046-1051.
44. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gilette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
45. Tiede B.J., Owens L.A., Li F., DeCosta C., Kang Y. A novel mouse model for non-invasive single marker tracking of mammary stem cells in vivo reveals stem cell dynamics throughout pregnancy. PLoS One 2009, 4:e8035.
46. Tsukamoto A.S., Grosschedl R., Guzman R.C., Parlow T., Varmus H.E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988, 55:619-625.
47. Vaillant F.A., Asselin-Labat M.-L., Shackleton M., Forrest N.C., Lindeman G.J., Visvader J.E. The mammary progenitor marker CD61/β3 identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res. 2008, 68:7711-7717.
48. Van Amerongen R., Bowman A.N., Nusse R. Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 2012, 11:1-14.
49. Van Keymeulen A., Rocha A.S., Ousset M., Beck B., Bouvencourt G., Rock J., Sharma N., Dekoninck S., Blanpain C. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-194.
50. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009, 23:2563-2577.
51. Wu A.H., Yu M.C., Tseng C.C., Pike M.C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer 2008, 98:9-14.
52. Zhang J.F., Chen L.H., Yuan Y.W., Xie G.Z., Sun A.M., Liu Y., Chen Z.X. STAT1 promotes radioresistance of CD44(+)/CD24(-/low) cells in breast cancer. Exp. Biol. Med. 2011, 236:418-422.
53. Zhou J., Wulfkuhle J., Zhang H., Gu P., Yang Y., Deng J., Margolick J.B., Liotta L.A., Petricoin E., Zhang Y. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16158-16163.